Literature DB >> 2206111

Effects of CGS 9896 in acute experimental intoxication with fluostigmine.

S Rump1, W Raszewski, T Gidynska, E Galecka.   

Abstract

The therapeutic effectiveness of CGS 9896, a novel potent anxiolytic and anticonvulsant, in organophosphate intoxication was studied. It was demonstrated that this drug, used as an adjunct to a mixture of atropine and obidoxime, led to a rise in the LD50 of fluostigmine in mice of more than 150 times and more than 138 times for 2 and 24 h, respectively. After 24 h, this effect was twice that of diazepam, which served as a reference drug.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2206111     DOI: 10.1007/bf01973465

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  10 in total

1.  USE OF MOVING AVERAGES AND INTERPOLATION TO ESTIMATE MEDIAN-EFFECTIVE DOSE: I. Fundamental Formulas, Estimation of Error, and Relation to Other Methods.

Authors:  W R Thompson
Journal:  Bacteriol Rev       Date:  1947-06

2.  Reduction by diazepam of repetitive electrical activity and toxicity resulting from soman.

Authors:  D D Johnson; H E Lowndes
Journal:  Eur J Pharmacol       Date:  1974-10       Impact factor: 4.432

3.  Investigations on the effects of diazepam in acute experimental intoxication with fluostigmine.

Authors:  S Rump; E Grudzińska
Journal:  Arch Toxikol       Date:  1974-02-28

4.  Effects of diazepam on epileptiform patterns of bioelectrical activity of the rabbit's brain induced by fluostigmine.

Authors:  S Rump; E Grudzinska; Z Edelwejn
Journal:  Neuropharmacology       Date:  1973-08       Impact factor: 5.250

5.  Effects of diazepam on abnormalities of bioelectrical activity of the rabbit's brain due to fluostigmine.

Authors:  S Rump; E Grudzińska; Z Edelwejn
Journal:  Act Nerv Super (Praha)       Date:  1972-08

Review 6.  Acute and long lasting central actions of organophosphorus agents.

Authors:  A G Karczmar
Journal:  Fundam Appl Toxicol       Date:  1984-04

7.  High affinity inhibition of [3H]-flunitrazepam binding to brain benzodiazepine receptors by CGS 9896, a novel pyrazoloquinoline.

Authors:  K W Gee; W D Horst; R O'Brien; H I Yamamura
Journal:  Biochem Biophys Res Commun       Date:  1982-03-30       Impact factor: 3.575

8.  A novel pyrazoloquinoline that interacts with brain benzodiazepine receptors: characterization of some in vitro and in vivo properties of CGS 9896.

Authors:  K W Gee; H I Yamamura
Journal:  Life Sci       Date:  1982-06-28       Impact factor: 5.037

9.  Effect of benzodiazepine derivatives on soman-induced seizure activity and convulsions in the monkey.

Authors:  J A Lipp
Journal:  Arch Int Pharmacodyn Ther       Date:  1973-04

10.  CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents.

Authors:  P S Bernard; D A Bennett; G Pastor; N Yokoyama; J M Liebman
Journal:  J Pharmacol Exp Ther       Date:  1985-10       Impact factor: 4.030

  10 in total
  1 in total

1.  Effects of imidazenil, a new benzodiazepine receptor partial agonist, in the treatment of convulsions in organophosphate intoxications.

Authors:  S Rump; T Gidynska; E Galecka; O Antkowiak; M Nawrocka; M Kowalczyk
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.